Top

World Journal of Urology

Published in:

25-07-2023 | Shockwave Therapy | Original Article

Low-intensity laser diode plus extracorporeal shock wave therapy: a new treatment strategy in the management of Peyronie’s disease

Authors: Lucio Dell’Atti, Piero Ronchi

Published in: World Journal of Urology | Issue 9/2023

Abstract

Purpose

To assess the clinical effectiveness of extra corporeal shockwave therapy (ESWT) administration compared with ESWT plus a low-intensity laser diode therapy (LILDT) in the management of Peyronie’s disease (PD) stable stage.

Methods

In this study, 214 patients affected by PD in stable stage (≥ 12 months), were divided into two groups. Group 1 (G1) counted 111 patients treated only with ESWT; Group 2 (G2) consisted of 103 patients that received ESWT with the same protocol of G1 plus LILDT for six weeks. The patients of both groups were assessed at baseline and follow-up for erectile function, painful erections, penile plaque size and penile curvature. The results were evaluated at baseline and 3, 6, 12 months after the treatment.

Results

Three months after the treatment in G2 pain in an erection or during intercourse was resolved completely in 78.6% of the patients, whereas in 55.8% cases of G1 (p < 0.003). G2 patients had a reduction of curvature degree after the 3 months treatment (p < 0.002). However, mean plaque size decreased in both groups without statistically differences with baseline values. Mean ± SD IIEF-5 score further improved significantly in the group treated with ESWT plus LILDT (p < 0.001). There were no permanent adverse sequelae after treatments.

Conclusion

This study demonstrates an interesting therapeutic strategy when combined to the synergistic action of a shock wave therapy with low-intensity laser therapy on the stable plaques with significant benefits in terms of pain perception, penile curvature and sexual activity.

Sharma KL, Alom M, Trost L (2020) The etiology of Peyronie’s disease: pathogenesis and genetic contributions. Sex Med Rev 8:314–323. https://doi.org/10.1016/j.sxmr.2019.06.004CrossRefPubMed

Dell’Atti L, Polito M, Galosi AB (2019) Is degloving the best method to approach the penile corporoplasty with Yachia’s technique? Urology 126:204–208. https://doi.org/10.1016/j.urology.2018.12.040CrossRefPubMed

Krieger JR, Rizk PJ, Kohn TP, Pastuszak A (2019) Shockwave therapy in the treatment of Peyronie’s disease. Sex Med Rev 7:499–507. https://doi.org/10.1016/j.sxmr.2019.02.001CrossRefPubMed

Campbell JD, Matti D, Abed H, Di Pierdominico A (2022) Technological advancements for treating erectile dysfunction and Peyronie’s disease. Urol Clin North Am 49:175–184. https://doi.org/10.1016/j.ucl.2021.07.013CrossRefPubMed

Bakr AM, El-Sakka AI (2021) Extracorporeal shockwave therapy in Peyronie’s disease: systematic review and meta-analysis. J Sex Med 18(10):1705–1714. https://doi.org/10.1016/j.jsxm.2021.06.012CrossRefPubMed

Hatzichristodoulou G, Meisner C, Gschwend J et al (2013) Extracorporeal shock wave therapy in Peyronie’s disease: results of a placebo-controlled, prospective, randomized, single-blind study. J Sex Med 10:2815–2821. https://doi.org/10.1111/jsm.12275CrossRefPubMed

Longo L, Longo D (2022) Laser Photobiomodulation of the Induratio Penis Plastica or La Peyronie’s Syndrome. Photobiomodul Photomed Laser Surg 40:287–291. https://doi.org/10.1089/photob.2021.0102CrossRefPubMed

Allameh F, Razzaghi M, Rayegani SM et al (2019) Laser therapy for Peyronie’s disease: a randomized control double-blind pilot study. J Lasers Med Sci 10:S37–S42. https://doi.org/10.15171/jlms.2019.S7CrossRefPubMedPubMedCentral

Bellorofonte C, Ruoppolo M, Tura M et al (1989) Possibility of using the piezoelectric lithotriptor in the treatment of severe cavernous fibrosis. Arch Ital Urol Nefrol Androl 61:417–422 (PMID: 2532407)PubMed

10.

Abdel-Salam Y, Budair Z, Renner C et al (1999) Treatment of Peyronie’s disease by extracorporeal shockwave therapy: evaluation of our preliminary results. J Endourol 13:549–552. https://doi.org/10.1089/end.1999.13.549CrossRefPubMed

11.

Palmieri A, Imbimbo C, Longo N et al (2009) A first prospective, randomized, double-blind, placebo-controlled trial evaluating extracorporeal shock wave therapy for the treatment of Peyronie’s disease. Eur Urol 46:363–370. https://doi.org/10.1016/j.eururo.2009.05.012CrossRef

12.

Hauck E, Hauptmann A, Bschleipfer T et al (2004) Questionable efficacy of extracorporeal shock wave therapy for Peyronie’s disease: results of a prospective approach. J Urol 171:296–299. https://doi.org/10.1097/01.ju.0000099891.68488.4eCrossRefPubMed

13.

Gao L, Qian S, Li J et al (2016) A meta-analysis of extracorporeal shock wave therapy for Peyronie’s disease. Int J Impot Res 28:161–166. https://doi.org/10.1038/ijir.2016.24CrossRefPubMed

14.

Shimpi R, Jineshkumar Jain R (2016) Role of extracorporeal shock wave therapy in management of Peyronie’s disease: a preliminary report. Urol Ann 8:409–417. https://doi.org/10.4103/0974-7796.192100CrossRefPubMedPubMedCentral

15.

Freitas CP, Melo C, Alexandrino AM, Noites A (2013) Efficacy of low-level laser therapy on scar tissue. J Cosmet Laser Ther 15(3):171–176. https://doi.org/10.3109/14764172.2013.769272CrossRefPubMed

16.

Claro JA, Passerotti CC, Figueiredo Neto AC et al (2004) An alternative non-invasive treatment for Peyronie’s disease. Int Braz J Urol 30:199–204. https://doi.org/10.1590/s1677-55382004000300004CrossRefPubMed

17.

Huang YY, Chen AC, Carroll JD, Hamblin MR (2009) Biphasic dose response in low level light therapy. Dose Response 7(4):358–383. https://doi.org/10.2203/dose-response.09-027.HamblinCrossRefPubMedPubMedCentral

18.

Johnson DE, John E Jr, Harris JM, Hawkins JH (1995) Low-level laser therapy for Peyronie’s disease. Lasers in surgery: advanced characterization, therapeutics, and systems V. International Society for Optics and Photonics. https://doi.org/10.1117/12.209091CrossRef

19.

Candebat Montero LH, Miranda Reyes PL, Díaz García F et al (2008) Peyronie’s disease: treatment with interferon and laser. Arch Esp Urol 61(3):413–423. https://doi.org/10.4321/s0004-06142008000300008CrossRefPubMed

Title: Low-intensity laser diode plus extracorporeal shock wave therapy: a new treatment strategy in the management of Peyronie’s disease
Authors: Lucio Dell’Atti
Piero Ronchi
Publication date: 25-07-2023
Publisher: Springer Berlin Heidelberg
Keywords: Shockwave Therapy
Laser
Published in: World Journal of Urology / Issue 9/2023
Print ISSN: 0724-4983
Electronic ISSN: 1433-8726
DOI: https://doi.org/10.1007/s00345-023-04533-6

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Low-intensity laser diode plus extracorporeal shock wave therapy: a new treatment strategy in the management of Peyronie’s disease

Abstract

Purpose

Methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 9/2023

U-shaped association between sleep duration and urgency urinary incontinence in women: a cross-sectional study

Letter to the editor for the article “Real-world outcomes of first-line chemotherapy for unresectable stage III and IV bladder cancer”

Long-term oncologic and functional outcomes following robot-assisted radical cystectomy and intracorporeal Padua ileal bladder: results from a single high-volume center

Cystoscopy, an indispensable tool for the diagnosis and prognosis of bladder pain syndrome, takes nomograms for predicting recurrence

Diagnostic accuracy of multiparametric MRI- and microultrasound-targeted biopsy in biopsy-naïve patients with a PI-RADS 5 lesion: a single-institutional study

Outcome of acute epididymo-orchitis: risk factors for testicular loss